ASPIC

envie a um amigo share this

3º Encontro Multidisciplinar Oncologia Urológica

Ordem dos Médicos, Secção Regional do Norte, Porto, Portugal

 

6-7 November, 2025

 

See more informations here: https://www.factorchave.com/3o-encontro-multidisciplinar-oncologia-urologica/

21.º Congresso Nacional de Cancro Digestivo

Hotel Eurostars Oasis Plaza, Figueira da Foz, Portugal

 

1-3 October, 2025

 

See more informations here: https://www.factorchave.com/21-congresso-nacional-cancro-digestivo/

21.º Congresso Nacional de Cancro Digestivo

Hotel Eurostars Oasis Plaza, Figueira da Foz, Portugal

 

1-3 October, 2025

 

See more informations here: https://www.factorchave.com/21-congresso-nacional-cancro-digestivo/

8as Atualizações do Cancro do Pulmão

Hospital CUF Tejo, Lisboa, Portugal

 

23 May, 2025

 

See more informations here: https://academiacuf.up.events/activities/view/12184#local

8as Atualizações do Cancro do Pulmão

Hospital CUF Tejo, Lisboa, Portugal

 

23 May, 2025

 

See more informations here: https://academiacuf.up.events/activities/view/12184#local

Estudo pré-clínico com Avatares de cancro de mama prevê resposta à quimioterapia

Autores e Afiliações:

Raquel V Mendes 1, Joana M Ribeiro # 2, Helena Gouveia # 3, Cátia Rebelo de Almeida 1, Mireia Castillo-Martin 1 4, Maria José Brito 4, Rita Canas-Marques 4, Eva Batista 3, Celeste Alves 3, Berta Sousa 3, Pedro Gouveia 3, Miguel Godinho Ferreira 5, Maria João Cardoso 3 6, Fatima Cardoso 3, Rita Fior 7

Zebrafish Avatar testing preclinical study predicts chemotherapy response in breast cancer

Authors and Affiliations:

Raquel V Mendes 1, Joana M Ribeiro # 2, Helena Gouveia # 3, Cátia Rebelo de Almeida 1, Mireia Castillo-Martin 1 4, Maria José Brito 4, Rita Canas-Marques 4, Eva Batista 3, Celeste Alves 3, Berta Sousa 3, Pedro Gouveia 3, Miguel Godinho Ferreira 5, Maria João Cardoso 3 6, Fatima Cardoso 3, Rita Fior 7

2nd International Portugal-USA Summer Course in Cancer Research

i3S, Porto, Portugal
 
30 June - 9 July 2025
 
See more informations here:

2nd International Portugal-USA Summer Course in Cancer Research

i3S, Porto, Portugal
 
30 June - 9 July 2025
 
See more information here: 

Isoquinolinequinone N-oxides with diverging mechanisms of action induce collateral sensitivity against multidrug resistant cancer cells

Work recently published in the “European Journal of Pharmacology" by Dr. Mélanie Barbosa, Dr. Ryan D. Kruschel et al., has demonstrated the potential of two isoquinolinequinone N-oxides (RK2 and RK3) as promising candidates for the next stages of drug development against multidrug resistant cancers, specifically linked to the overexpression of ABCB1. This work is the result of a collaboration of Prof. Helena Vasconcelos from i3S, University of Porto - Portugal, with Prof. Florence McCarthy, from the School of Chemistry, University College Cork - Ireland.